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Abstract 
Estrogenic potential of environmental samples is frequently assessed using receptor-
based functional assays. Using the Yeast Estrogen Screen (YES) developed by Routledge and 
Sumpter, we assessed the ability of cadmium to activate the estrogen receptor-mediated 
response. No induced transcriptional activity was observed with a range of CdCl2 
concentrations (1nm-1mM). But, when combining cadmium with the model compound 17β-
estradiol, cadmium was able to significantly potentiate the induced estrogenic response for 
concentrations ranging from 15 nM to 1 µM. A maximal effect was observed at 0.5 µM with a 
ten fold reduction of the 17β-estradiol EC50.  
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Important efforts have been made for the development of screening strategies to 
evaluate and understand endocrine disruption by estrogenic compounds in human and 
wildlife. Various in vitro tests have been developed and are used to assess the estrogenicity of 
isolated compounds or complex environmental mixtures. One of the most widely used in vitro 
tests is the yeast estrogen screen (YES; Routledge and Sumpter, 1996). 
Metals, and particularly cadmium, have already been shown to act in vivo as endocrine 
disruptors. But action through a direct estrogenic pathway is still unclear. Several studies have 
found an in vitro estrogenic activity of cadmium. Cadmium induced growth in the human 
breast cancer cell line MCF-7 (Garcia-Morales et al., 1994, Choe et al, 2003). Stoica et al. 
(2000) showed that cadmium is able to activate the estrogen receptor by binding to the 
hormone binding domain of the receptor. Choe et al. (2003) and Wilson et al. (2004) also 
observed induction of an estrogen receptor-dependent transcriptional expression assay (MCF-
7-ERE or TD47 cell lines). 
But contradictory results have been reported. Le Guevel et al. (2000) used yeast cells 
transfected with rainbow trout estradiol receptor and observed that cadmium alone is unable 
to activate the receptor. Silva et al. (2006) using the YES and E-screen assays (MCF-7 
proliferation) concluded a lack of activity of cadmium in both tests. In view of these 
contradictory results, this study aimed to assess the estrogenicity of a wide range of cadmium 
concentrations and to evaluate its potential to modulate the 17--estradiol activity in the YES 
assay. 
CdCl2 was obtained from Sigma-Aldrich. From 10mM CdCl2 stock solution, 21 
different concentrations ranging from 1 mM to 1 nM were obtained by serial dilution in water 
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then sterilized by 0.22 µm filtration. Yeast estrogen screen was conducted according to 
Routledge and Sumpter (1996). A serial dilution of estradiol-17 in ethanol was used as 
reference for the test. 10 µl of each dilution were added to wells. “Metal alone” and blank 
wells received 10 µl ethanol instead. 20 µl of cadmium solutions were then added to wells, 
while “estradiol alone” and blank wells received 20 µl water. Finally, 180 µl of assay medium 
and yeast were added to the wells. Plates were incubated 48 hours at 30°C before absorbance 
reading. In the yeast estrogen screen, the activation of estrogen receptor leads to its binding to 
estrogen response element then subsequent synthesis of -galactosidase. The galactosidase 
hydrolyses the chlorophenol red-galactopyranoside present in the medium. The chlorophenol-
red produced was measured by absorbance at 540nm. Absorbance at 620 nm allows 
correction for turbidity: corrected absorbance = Abs540nm - (Abs620nm –Abs620nm blank). 
We first tested the ability of CdCl2 to directly activate the ER-mediated response in the 
YES assay. Fig. 1 indicates that none of the tested cadmium concentrations resulted in any 
significant galactosidase activity as previously reported in other studies using yeast cells (Le 
Guevel et al., 2000; Silva et al., 2006). Although the human estrogen receptor and the 
estrogen response element have been inserted in the yeast strain, it appears that the YES assay 
can generate results that are different from those obtained with mammalian cell lines. Indeed 
several studies have reported that cadmium can activate the human reporter by interacting 
with the ligand-binding domain and exerts effects characteristic of the endogenous hormone 
in human cells (Stoica et al., 2000; Choe et al., 2003; Wilson et al., 2004). 
In a second experiment, we assessed the putative joint action of cadmium and the 
model compound 17β-estradiol (E2). 21 different concentrations (from 1nM to 1 mM) of 
cadmium were tested in combination with 11 E2 concentrations (10pM to 10nM). Results are 
shown in Fig. 2. Different effects were observed according to the cadmium concentration in 
the test medium. Cadmium concentrations from 1 to 500 nM potentiated the estrogenic 
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activity in a dose-dependant manner (although significant differences were only obtained for 
concentrations of 15 nM CdCl2 and higher). For each curve, the maximum induction was not 
affected but the EC50 decreased. Maximum effect (EC50 reduced to one tenth of the control 
value) was observed with 0.5 µM CdCl2. 
Cadmium concentrations from 1 to 20 µM reduced the enzymatic activity in a dose 
dependent manner. The decreased activity appeared to be, at least, partly due to toxicity as 
indicated by the reduced absorbance at 620nm (not shown). The curve obtained with 2 µM 
CdCl2 did not differ significantly to the standard curved obtained with E2 alone but a rapid 
decrease in galactosidase activity was observed for higher concentrations. Finally, at 
cadmium concentrations from 30 µM to 1 mM CdCl2, yeast growth was inhibited.  
These results show that cadmium can either potentiate the estrogenic response or have 
toxic effects on yeast metabolism. Reports from Silva et al. (2006) and Le Guevel et al. 
(2000) did not show potentiating effect of cadmium on their yeast-based assay but significant 
decrease in the response possibly due to toxicity. It should be stressed that only a few 
cadmium concentrations together with E2 were tested in these studies. Le Guevel and 
colleagues incubated the cells in 10 µM cadmium only, a concentration which was already 
toxic in this study. Cadmium toxicity at 10 µM or higher concentrations of cadmium has 
recently been reported either in the YES or in the E-screen assays.  
The reason why cadmium cannot directly activate the response mediated by the human 
estrogen receptor in the YES assay is unclear. But results obtained in this study indicate that 
cadmium can potentiate the estrogenic response induced by the interaction of E2 with the ER. 
This effect was not due to an enhanced metabolic activity as cadmium did not significantly 
increase yeast growth at effective concentrations (data not shown). Predki and Sarkar (1994) 
showed that cadmium, copper and chromium can interact with the zinc finger DNA-binding 
domain of the ER and activate gene transcription. These effects may have also occurred in our 
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study and account for the observed response. In conclusion, these results add further evidence 
that cadmium may act as potent endocrine disrupter and may increase the effect of 
hormonally-active compounds. 
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Figure Captions 
 
Fig. 1. Effect of 17-estradiol (E2) and cadmium in the recombinant yeast estrogen screen 
(YES). 
 
Fig. 2. Variation of yeast estrogen screen response to 17-estradiol with increasing 
concentrations of cadmium. The standard curve obtained with 17-estradiol (E2) alone is 
indicated with the error bars (n=14). Added cadmium concentrations are indicated in the table 
for each numbered curves. Plain lines indicate a decreased E2 EC50, dotted lines indicate an 
increased E2 EC50 with increasing cadmium concentrations. Curves 2, 3, 4, 6 and 7 are not 
displayed to gain clarity. Curves with E2 + cadmium were derived from two independent 
experiments. 
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Figure 2 
 
curve 
number
cadmium 
concentration (M)
1 9.54E-10
2 1.91E-09
3 3.81E-09
4 7.63E-09
5 1.53E-08
6 3.05E-08
7 6.10E-08
8 1.22E-07
9 2.44E-07
10 4.88E-07
11 9.77E-07
12 1.95E-06
13 3.91E-06
14 7.81E-06
15 1.56E-05
16 3.13E-05
17 6.25E-05
18 1.25E-04
19 2.50E-04
20 5.00E-04
21 1.00E-03
Estradiol concentration (M)
Co
rr
e
ct
ed
 
ab
so
rb
an
ce
0.5
1
1.5
2
2.5
3
3.5
1.E-11 1.E-10 1.E-09 1.E-08
16-21
15
14
13
1211
10 9 8 5 1
 
